Verve Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2021 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Verve Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2021 to Q2 2024.
  • Verve Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 1, 2024 was 84.6M shares, a 32.8% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 84.6M +20.9M +32.8% Aug 1, 2024 10-Q 2024-08-08
Q1 2024 84M +22.1M +35.8% May 2, 2024 10-Q 2024-05-08
Q4 2023 83.6M Dec 31, 2023 10-K 2024-02-27
Q3 2023 63.8M +2.15M +3.49% Oct 31, 2023 10-Q 2023-11-07
Q2 2023 63.7M +3.78M +6.3% Aug 3, 2023 10-Q 2023-08-10
Q1 2023 61.8M +13.3M +27.3% Feb 27, 2023 10-K 2023-03-02
Q3 2022 61.6M +13.4M +27.9% Nov 3, 2022 10-Q 2022-11-07
Q2 2022 59.9M +12M +24.9% Aug 4, 2022 10-Q 2022-08-09
Q1 2022 48.6M Mar 9, 2022 10-K 2022-03-14
Q3 2021 48.2M Nov 8, 2021 10-Q 2021-11-10
Q2 2021 48M Aug 9, 2021 10-Q/A 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.